Mannatech (NASDAQ:MTEX) Stock Passes Below 200-Day Moving Average – Should You Sell?

Mannatech, Incorporated (NASDAQ:MTEX) shares crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $8.30 and traded as low as $6.42. Mannatech shares last traded at $6.86, with a volume of 3,602 shares.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Mannatech in a research report on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, According to MarketBeat, Mannatech currently has a consensus rating of “Sell”.

Mannatech Stock Up 1.6%

The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.56 and a current ratio of 1.13. The stock’s fifty day simple moving average is $7.18 and its two-hundred day simple moving average is $8.30. The company has a market capitalization of $13.03 million, a price-to-earnings ratio of -7.98 and a beta of 0.81.

Mannatech Company Profile

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.